Vasista Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 9.00 Cr
as on 17-11-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 61.31 Cr
as on 17-11-2024
- Satisfied Charges ₹ 27.36 Cr
as on 17-11-2024
- Revenue 8.98%
(FY 2023)
- Profit 20.69%
(FY 2023)
- Ebitda 8.08%
(FY 2023)
- Net Worth 14.13%
(FY 2023)
- Total Assets -3.06%
(FY 2023)
About Vasista Pharma Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹61.31 Cr. The company has closed loans amounting to ₹27.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Potturi Raju, Raja Potturi, Potturi Varma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24297AP2015PTC096994
- Company No.
096994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vasista Pharma Chem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Potturi Raju  | Managing Director | 15-Jul-2015 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vegiraju Raju | Director | 17-Aug-2018 | Current |
| Satya Kanumuri | Director | 17-Aug-2018 | Current |
| Raja Potturi | Director | 17-Aug-2018 | Current |
| Potturi Varma | Additional Director | 28-Nov-2022 | Current |
Financial Performance of Vasista Pharma Chem.
Vasista Pharma Chem Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.98% increase. The company also saw a substantial improvement in profitability, with a 20.69% increase in profit. The company's net worth Soared by an impressive increase of 14.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vasista Pharma Chem?
In 2023, Vasista Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasista Life Sciences Private LimitedActive 14 years 9 monthsPotturi Raju, Raja Potturi and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Apr 2024 | ₹10.00 Cr | Open |
Others Creation Date: 31 Mar 2024 | ₹9.95 M | Open |
Others Creation Date: 24 Aug 2022 | ₹13.95 Cr | Open |
How Many Employees Work at Vasista Pharma Chem?
Unlock and access historical data on people associated with Vasista Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vasista Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vasista Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
